Search
CYNK-101
go.drugbank.com/drugs/DB18637InvestigationalCYNK-101 is an allogeneic human placental hematopoietic stem cell-derived natural killer (NK) cell therapy product that is genetically modified to express a variant of CD16 (CD16VP).
[Methyltelluro]Acetate
go.drugbank.com/drugs/DB01918ExperimentalThese are organic compounds containing an oxoanion. This medication targets the protein monomeric sarcosine oxidase.
Famitinib
go.drugbank.com/drugs/DB11741InvestigationalFamitinib has been used in trials studying the treatment of Colorectal Cancer, Renal Cell Cancer, Colorectal Cancer Recurrent, Colorectal Cancer Metastatic, and Metastatic Renal Cell Cancer, among others
Cenicriviroc
go.drugbank.com/drugs/DB11758InvestigationalCenicriviroc has been used in trials studying the treatment of HIV-infection/AIDS, AIDS Dementia Complex, Nonalcoholic Steatohepatitis, Human Immunodeficiency Virus, and HIV-1-Associated Cognitive Motor
HPV-16 trojan peptide vaccine
go.drugbank.com/drugs/DB17496InvestigationalHPV-16 trojan peptide vaccine is an investigational cancer immunotherapy consisting of a novel Trojan peptide complex, composed of human papilloma virus 16 (HPV 16) epitopes, to stimulate antigen-specific
Ivarimod
go.drugbank.com/drugs/DB19605ExperimentalThe usage of the INN stem '-imod' in the name indicates that Ivarimod is a immunomodulator, both stimulant/suppressive and stimulant. Ivarimod has a monoisotopic molecular weight of 512.33 Da.
Epertinib
go.drugbank.com/drugs/DB20062ExperimentalThe usage of the INN stem '-ertinib' in the name indicates that Epertinib is a epidermal growth factor receptor (EGFR) inhibitor. Epertinib has a monoisotopic molecular weight of 559.18 Da.
Quiflapon
go.drugbank.com/drugs/DB20376ExperimentalThe usage of the INN stem '-flapon' in the name indicates that Quiflapon is a 5-lipoxygenase-activating protein (FLAP) inhibitor. Quiflapon has a monoisotopic molecular weight of 586.21 Da.
Burapitant
go.drugbank.com/drugs/DB20607ExperimentalThe usage of the INN stem '-pitant' in the name indicates that Burapitant is a neurokinin NK1 (substance P) receptor antagonist. Burapitant has a monoisotopic molecular weight of 681.2 Da.
P-113D
go.drugbank.com/drugs/DB04987ExperimentalP-113D is a novel 12 amino-acid antimicrobial peptide drug derived from histatins, which are compounds found naturally in human saliva.